Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis

OBJECTIVE: It has been hypothesised that the use of ACE inhibitors and angiotensin receptor blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The findings from the available observational studies varied, and summary estimates are urgently needed to elucidate whet...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Heart
Huvudupphovsmän: Flacco, Maria Elena, Acuti Martellucci, Cecilia, Bravi, Francesca, Parruti, Giustino, Cappadona, Rosaria, Mascitelli, Alfonso, Manfredini, Roberto, Mantovani, Lorenzo G, Manzoli, Lamberto
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2020
Ämnen:
Cardiac Risk Factors and Prevention
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7371482/
https://ncbi.nlm.nih.gov/pubmed/32611676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2020-317336
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk